# Kaida BioPharma Inc. — Form D

Kaida BioPharma Inc. of FORT LAUDERDALE, FL, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-21. The offering totals $3.0M, of which $1.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-01-21
- Form: D
- Accession: 0001493152-26-003028
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.6M
- Remaining: $1.4M
- Investors: 42
- Date of first sale: 2023-10-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-570572

## Issuer

- Name: Kaida BioPharma Inc.
- CIK: 0001973954
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 416 SW 1ST AVENUE, FORT LAUDERDALE, FL, 33301
- Phone: (917) 683-3092

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Stella Vnook | Director | Kenmore, NY |
| Stephen Dunn | Director | Fort Lauderdale, FL |
| Craig Pierson | Director | Fort Lauderdale, FL |
| Craig Pierson | Executive Officer | Fort Lauderdale, FL |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-06-14](https://search.stillhousedata.com/formd/0001731122-23-001124) | D | $4K | $4K |

## More

- [CIK 1973954 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1973954&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001493152-26-003028.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.